AGE/RAGE axis regulates reversible transition to quiescent states of ALK-rearranged NSCLC and pancreatic cancer cells in monolayer cultures

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
AGE/RAGE axis regulates reversible transition to quiescent states of ALK-rearranged NSCLC and pancreatic cancer cells in monolayer cultures ; volume:12 ; number:1 ; day:14 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (14.6.2022), 1-13, 12.2022

Creator
Kadonosono, Tetsuya
Miyamoto, Kotaro
Sakai, Shiori
Matsuo, Yoshiyuki
Kitajima, Shojiro
Wang, Qiannan
Endo, Minori
Niibori, Mizuho
Kuchimaru, Takahiro
Soga, Tomoyoshi
Hirota, Kiichi
Kizaka-Kondoh, Shinae
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-022-14272-0
URN
urn:nbn:de:101:1-2022080822044137272222
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kadonosono, Tetsuya
  • Miyamoto, Kotaro
  • Sakai, Shiori
  • Matsuo, Yoshiyuki
  • Kitajima, Shojiro
  • Wang, Qiannan
  • Endo, Minori
  • Niibori, Mizuho
  • Kuchimaru, Takahiro
  • Soga, Tomoyoshi
  • Hirota, Kiichi
  • Kizaka-Kondoh, Shinae
  • SpringerLink (Online service)

Other Objects (12)

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer

Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer

Gingival Metastasis of ALK Rearranged Non-Small Cell Lung Cancer

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC

Successful Treatment of a Resistant Subclone in ALK-Rearranged NSCLC

Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia

Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia

Eroded telomeres are rearranged in quiescent fission yeast cells through duplications of subtelomeric sequences

Eroded telomeres are rearranged in quiescent fission yeast cells through duplications of subtelomeric sequences

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma

Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation

First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report

First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report

Related objects